Detalhe da pesquisa
1.
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers.
Gynecol Oncol
; 155(2): 262-269, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31604666
2.
Nivolumab in recurrent/metastatic head and neck cancers.
Future Oncol
; 14(7): 603-609, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29130342
3.
Immunotherapy in head and neck cancer: a new paradigm.
Anticancer Drugs
; 29(5): 385-386, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29649037
4.
HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments.
Cancers (Basel)
; 15(6)2023 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980624
5.
Analysis of the benefit of salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck.
Oral Oncol
; 145: 106533, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37562096
6.
Methods and Designs of Modern Breast Cancer Confirmatory Trials.
Cancers (Basel)
; 13(11)2021 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34199352
7.
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives.
Cancers (Basel)
; 13(19)2021 Sep 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638325
8.
Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes.
Cancers (Basel)
; 13(10)2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34068892
9.
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and Perspectives.
Cancers (Basel)
; 12(9)2020 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32854393
10.
Induction chemotherapy in head and neck cancers: Results and controversies.
Oral Oncol
; 95: 164-169, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345386
11.
L'immunothérapie dans les cancers ORL.
Bull Cancer
; 105 Suppl 1: S35-S42, 2018 Dec.
Artigo
em Francês
| MEDLINE | ID: mdl-30595197